Literature DB >> 1960228

Prognostic value of morphometry in breast cancer.

J P Baak, J C van der Linden, P J van Diest.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1960228      PMCID： PMC496683          DOI： 10.1136/jcp.44.10.876-a

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  9 in total

1.  The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients.

Authors:  P J van Diest; J P Baak
Journal:  Hum Pathol       Date:  1991-04       Impact factor: 3.466

2.  Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.

Authors:  J S Meyer; W C Bauer; B R Rao
Journal:  Lab Invest       Date:  1978-09       Impact factor: 5.662

3.  The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients.

Authors:  J C van der Linden; J Lindeman; J P Baak; C J Meijer; C J Herman
Journal:  Cytometry       Date:  1989-01

4.  Correlation between morphometrical parameters and disease-free survival in ductal breast cancer treated only by surgery.

Authors:  P Tosi; P Luzi; V Sforza; R Santopietro; M Bindi; E Tucci; P Barbini; J P Baak
Journal:  Appl Pathol       Date:  1986

5.  Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up.

Authors:  A M Uyterlinde; J P Baak; N W Schipper; H Peterse; E Matze; C J Meijer
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

6.  Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.

Authors:  J C van der Linden; J P Baak; J Lindeman; J Hermans; C J Meyer
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

7.  The value of morphometry to classic prognosticators in breast cancer.

Authors:  J P Baak; H Van Dop; P H Kurver; J Hermans
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

8.  The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands.

Authors:  J P Baak; P J van Diest; A T Ariens; M W van Beek; S M Bellot; J Fijnheer; L H van Gorp; W S Kwee; J Los; H C Peterse
Journal:  Pathol Res Pract       Date:  1989-11       Impact factor: 3.250

9.  Cell kinetics as a prognostic marker in node-negative breast cancer.

Authors:  R Silvestrini; M G Daidone; G Gasparini
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.